Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
Investigators are evaluating the feasibility, safety and early efficacy of administering a commercially available dietary supplement containing potato-based resistant starch to subjects undergoing allogeneic SCT (stem cell transplant). The intervention will begin immediately prior to the conditioning phase and continue through day 100. Investigators hypothesize that short term administration of a resistant starch is capable of increasing levels of butyrate within the intestine that will reduce rates of acute GVHD (Graft-Versus-Host Disease).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
105 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Mary M Riwes, D.O
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal